keytruda - pembrolizumab injection, powder, lyophilized, for solution
(Pembrolizumab)Merck Sharp & Dohme Llc
Usage: Keytruda is a PD-1-blocking immunotherapy indicated for numerous cancers including melanoma, non-small cell lung cancer, head and neck cancer, bladder cancer, colorectal cancer, gastric cancer, cervical cancer, renal cell carcinoma, endometrial carcinoma, triple-negative breast cancer, and other solid tumors.